Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine

By Martin S.L.   Borrow R.   van der Ley P.   Dawson M.   Fox A.J.   Cartwright K.A.V.  

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2476-2481

Elsevier

Access to resources Recommend Favorite

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

By Peeters C.C.A.M.   Rumke H.C.   Sundermann L.C.   van der Voort E.M.R.   Meulenbelt J.   Schuller M.   Kuipers A.J.   van der Ley P.   Poolman J.T.  

Vaccine, Vol. 14, Iss. 10, 1996-07 ,pp. : 1009-1015

Elsevier

Access to resources Recommend Favorite

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins

By Cartwright K.   Morris R.   Rumke H.   Fox A.   Ray Borrow   Begg N.   Richmond P.   Poolman J.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2612-2619

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers

By Drabick J.J.   Brandt B.L.   Moran E.E.   Saunders N.B.   Shoemaker D.R.   Zollinger W.D.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 160-172

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age

By de Kleijn E.D.   de Groot R.   Labadie J.   Lafeber A.B.   van den Dobbelsteen G.   van Alphen L.   van Dijken H.   Kuipers B.   van Omme G.-W.G.-W.   Wala M.   Juttmann R.   Rumke H.C.  

Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. : 1456-1466

Elsevier

Access to resources Recommend Favorite